Cinnarizine Tablets

This product is a piperazine calcium channel antagonist, which can block calcium influx into vascular smooth muscle, causing vasodilation and improving cerebral and coronary circulation, especially having a certain selective effect on cerebral blood vessels. This product can inhibit phosphodiesterase, prevent cAMP from decomposing into inactive 5-AMP, thereby increasing the concentration of cAMP in cells, inhibiting the release of various biologically active substances such as histamine, 5-hydroxytryptamine, bradykinin, and also inhibiting the activation of complement C4. The lethal dose for humans is 100-500 mg/kg, and the LD50 (oral administration to mice and rats) is greater than 1g/kg.

Cinnarizine

This product is white or off-white tablets.

For cerebral thrombosis, cerebral embolism, brain<Aclass=bluehref=http://jbk.39.net/keshi/neike/xxgnk/49039.htmltarge

Oral administration, 25-50 mg each time, 3 times a day.

Common symptoms include drowsiness, fatigue, and weight gain in some patients (generally transient). Long-term use may occasionally cause depression and extrapyramidal reactions, such as bradykinesia, rigidity, akathisia, dry mouth, muscle pain, and rash.

Patients with a history of allergy to this drug or a history of depression are contraindicated using this drug.

Precautions for children: follow doctor's advice. Precautions for pregnancy and lactation: follow doctor's advice. Precautions for the elderly: follow doctor's advice.

1. When used in combination with alcohol, hypnotics or sedatives, the sedative effect is aggravated. 2. When used in combination with phenytoin sodium and carbamazepine, the blood concentration of cinnarizine can be reduced.

Shade, sealed and stored

25mg

24 months

Guangdong P.D.Pharmaceutical Co., Ltd.

• Founded in:

  1994-08-15

• Address:

  No. 66, Bidi Avenue, Yueshan Town, Kaiping City, Guangdong Province

• Tax NO.:

  91440700617754849P

• Registered Funds:

  $6 million

• Website:

  Log in to view

• Email:

  Log in to view